Hong Kong Regenerative Medisun Industry and academic circles established under the auspices of the Medisun Medical Group

Medisun launched the “Hong Kong Regenerative Medisun Association”

On May 28, 2018, the Hong Kong Regenerative Medisun Association, which was initiated by representatives from the Hong Kong Regenerative Medisun Industry and academic circles, was formally established under the auspices of the Medisun Medical Group.

Hong Kong Regenerative Medisun Association goals

The Hong Kong Regenerative Medisun Association was founded by experts, scholars, industry representatives and people of insight in the field of regenerative Medisun in Hong Kong and around the world. The purpose of the association is to establish a consensus platform for the regenerative Medisun industry in Hong Kong, promote the development of the regenerative Medisun industry, encourage and promote international cooperation, and propose to the Hong Kong SAR government the recommendations of the regenerative Medisun industry on industry regulations and actively influence industry rules. The establishment and improvement of the company provides effective technical and management advice to the Hong Kong government, Hong Kong public health agencies and companies in the industry.

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

On the afternoon of May 28, representatives from Hong Kong’s medical health, regenerative Medisun and biotechnology fields, doctors, pharmacists, chemists and university researchers gathered to discuss and elect the first council of the Hong Kong Regenerative Medisun Association.They read the charter of the association and clarify the duties of the board. At the same time, they have had a heated discussion on the regulatory documents issued by the Hong Kong SAR Government on Advanced Therapy Products. They agreed to regulate the direction of document guidance and proposed a number of issues that need to be clarified, including:

1. Professional qualifications required by the licensee of the Regenerative Medisun and Stem Cell Research and Development Organization;

2. Advanced Therapy Products is regulated by the Pharmacy and Poisons Ordinance (Cap. 138). However, since the production process and user definition of cellular products and pharmaceutical products are different, they should be clarified accordingly;

3. With reference to the requirements of the international GMP/PICS standard, which standard should be achieved in the cell laboratory qualification of existing regenerative Medisun institutions;

4. After the specific regulation is in force, whether there should be a transition period, so that the industry has time to adjust and cooperate;

5. Submit the Advanced Therapy Products comments and submit them to the Hong Kong Department of Health.

Member of the First Council of the Hong Kong Regenerative Medisun Association

Position

Name

 Qualifications

Chairman

Danny Wong Mr. Wang Xiaofeng

 Founder and Chairman of Medisun Medical Group, years of investment experience in the field of regenerative Medisun, understanding the development and trends of the biotechnology industry

Vice President

Joseph Wang  Dr. Wang Qiyuan

Registered as a doctor, founder of the Hong Kong Stem Cell Center, enriching the clinical experience of regenerative Medisun

Vice President

David Leung Mr. Liang Yaoming

Registered pharmacist, familiar with pharmaceutical regulations and GMP requirements

Vice Chairman

Gregory Cheng Professor Zheng Yanming

Hematology expert, Professor of the University of Macau Health Sciences

Director | Treasurer

Kenneth Lee Dr. Li Zhisheng

Registered as a doctor, B Q Anti-aging Center Consultant

Director

Philip Choy Dr. Cai Shaolong

Ph.D. in Natural Medisun, Madison Biomedical Director

Director

Daniel Tam Dr. Tan Yizhu

Registered as a medical laboratory technologist, director of the Trans-Olympic Blood Bank Laboratory, focusing on cell culture technology for many years

Director

Vivien Leung Ms. Liang Yiqun

 Registered as a medical laboratory technologist, manager of the Trans-Olympic Blood Bank Laboratory, familiar with quality management

Director

Chris Wong Dr. Huang Libao

 Registered as a medical laboratory technologist, director of HKMDPC, molecular biodiagnostic expert

Secretary

Sidney Tam Dr. Tan Guozhen

Chief Executive Officer, Life Clinic, Health Management Consultant

Secretary

Allen Chan Mr. Chen Yuxin

Registered as a medical laboratory technologist, familiar with quality management

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

Hong Kong Regenerative Medisun Association’s recent work plan

Next, the Hong Kong Regenerative Medisun Association will issue letters to the organizations including the Hong Kong Department of Health, the Hong Kong Stock Exchange, the Hong Kong University Biomedical Science, Life Sciences, and the Global Regenerative Medisun Alliance (ARM). include:

1. Announced the official establishment of the Hong Kong Regenerative Medisun Association

2. Announce the initial membership list of the Hong Kong Regenerative Medisun Council, association charter, association vision and goals

3. Call for the support and participation of experts, scholars and industry representatives from Hong Kong and around the world

4. Propose to the Hong Kong Government to clarify regulatory regulations on Advanced Medisun and Advanced Therapy Products

Special thanks

Thank you for taking the time to attend the representatives of the institutions, including:

Medisun Medical Group | Medisun Reproductive Medisun Center

Hong Kong Life Science and Technology Group Co., Ltd.

Standard Pathology Laboratory Co., Ltd.

BIH

Living Tissues company limited

BIB Health Care Centre

Hongxin Medical Center

Austa beauty

Hong Kong International Regenerative Medisun Centre

HKMPDC

Huixin Technology

Guangzhou Biological Institute

Trans-along cord blood bank

Hong Kong Stem Cell Center

Life Length

Biocell

Cordlife

For more information, please visit http://www.medisun.hk/

The famous American vaccine company Profectus settled in Hong Kong

The famous American vaccine company Profectus settled in Hong Kong

First recommend HPV cervical cancer treatment vaccine

BALTIMORE, MARYLAND, USA and HONG KONG, April 20, 2018

Profectus Biotech and Medisun Medical Group today announced the opening of a new joint venture in Hong Kong. The primary mission of the new company, ProMed BioSciences, Ltd., is to establish a leading vaccine company focused on the development of preventive and therapeutic vaccines for infectious diseases and cancer. The joint venture will leverage Profectus’ vaccine development expertise, clinically proven vaccine platform technology and a developing vaccine product line, in line with Medisun’s expertise, established clinical network and market access capabilities, expected in the second half of 2018 to put into operation.

The company’s first product development program will focus on the development, production and commercial application of prophylactic and therapeutic vaccines for HPV (human papillomavirus)-related lesions and cervical cancer [based on PBSVax® technology developed by Profectus]. ProMed BioSciences also plans to develop and treat hepatitis C virus (HCV), hepatitis B virus (HBV), herpes simplex virus (HSV), respiratory syncytial virus (RSV), and human immunodeficiency virus (HIV). Chikungunya and Zika, as well as personalized vaccines to treat cancer. The joint venture is expected to launch new vaccines in their respective markets, which will help promote the development of new vaccines, but ultimately the goal is to benefit patients around the world.

Mr. Jeffery Meshulam (first from left), President of Profectus Biotechnology, Mr. Terry Lierman (second from left), Chairman of Medivh Medical Group, and Mr. Danny Wong (fourth from right), founder and executive chairman of Medisun Medical Group, at Profectus ,USA.

– Long-term strategic cooperation to address the huge demand for prevention and treatment of infectious diseases and cancer in Asia

-Profectus’ expertise in vaccine development and platform technology, combined with Medisun’s localized expertise and experience, to establish a leading Hong Kong vaccine company focused on serving Asia

“This strategic cooperation will help establish Profectus’ business in Hong Kong and China. Through close cooperation with Medisun, we can assist Hong Kong and China to develop advanced vaccine technology to help prevent and treat Asian patients. Mr. Jeffrey Meshulam, President of Profectus, said, “We are pleased to be able to work with recognized local partners to achieve the highest standards of scientific research and development integration and medical services.”

“This collaboration will help Profectus and Medisun to jointly produce life-saving vaccines for infectious diseases and cancer, and address the huge medical needs that have not been met in Hong Kong, China and Asia.” Mr. Danny Wong, founder and executive chairman of Medisun Medical Group, said “ProMed BioSciences will leverage Profectus’ expertise in vaccine development and technology, combined with Medisun’s local expertise and close links with healthcare facilities in Hong Kong and China, and government medical regulatory agencies to develop vaccines to provide leadership for Asian patients disease prevention and treatment programs.”

ProMed BioSciences will focus on the following:

• Conduct technical research in Hong Kong or China

• Conduct clinical trials in Hong Kong or China

• Promote the expansion of Medisun Medical Center

• Develop vaccines to address disease prevention needs

• leverage to maximize the expertise of both partners

Mr. Jeffery Meshulam, President of Profectus Biotechnology (first from left), Mr. Terry Lierman, Chairman of Medisun Medical Group (first from right), Mr. Danny Wong, founder and executive chairman of Medisun Medical Group (middle), at the US headquarters of  Profectus.

About ProMed BioSciences

ProMed BioSciences Limited is a joint venture between Profectus BioSciences (USA) and Medisun Medical Group (Hong Kong) in Hong Kong to develop and conduct new vaccine clinical trials and commercial applications to address infectious diseases and cancer in Asia with the huge demand for prevention and treatment.

About Medisun

Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative Medisunne products, as well as quality hospitals and treatment centers. Medisun invests extensively in the fields of regenerative and stem cell patent technology, including stem cell therapy for heart failure, stem cell therapy for liver disease, kidney disease, nervous system disease, cancer, AIDS, and immune cell therapy for a variety of cancers. Medisun and Harvard University Stem Cell Research Institute, Johns Hopkins Medical School Life Science Center, Tsinghua University and other institutions have long-term cooperation plans to jointly invest in regenerative and stem cell therapy technology, with Medisun as a cooperative business The holding entity and holds global intellectual property rights. Medisun and the University of Maryland’s Institute of Human Virology (IHV) set up a technology clinical trial and development platform for viruses and cancer. Based on the Medisun Biomedical Laboratory in Hong Kong, Radiation will jointly build medical clinics in China and Asia. The experimental resource network promotes the world’s largest clinical research and development platform for virus research and cancer treatment technology. The Medisun Reproductive Centre is located at the Proud Square in Kowloon Bay, Hong Kong. It has a 50,000 square foot stem cell GMP production base, a cancer treatment centre and an anti-aging centre. It brings together European, Japanese, American and individual Chinese experts to develop a rigorous and professional R&D process. Provides immune cell therapy and a variety of stem cell health treatments.

For more information, please visit http://www.medisun.hk/

About Profectus BioSciences

Profectus BioSciences is a clinical stage vaccine development company focused on developing new vaccines for infectious disease and cancer prevention and treatment. The Profectus vaccine is based primarily on the company’s proprietary VesiculoVax™ and DNA vaccine technology platform. By simply using the VesiculoVax™ vaccine alone, B cells can be rapidly expanded to provide protection against emerging infectious diseases that threaten public health and biodefense mechanisms, such as Ebola, Marburg, Chikungunya, Zika virus, equine encephalitis virus, and respiratory syncytial virus. When VesiculoVax™ is used as a vaccine when the immune system is launched with the best pDNA vaccine, the Vesiculo Vax™-directed vaccine expands the triggered T cells into effector cells, which are ideal for attacking virus-infected cells and cancer. Current projects using the Prime / Boost Vaccine System (PBS Vax™) strategy include hepatitis B virus (HBV), human papillomavirus (HPV), herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus ( HIV). Partners and collaborators include UTMB’s Galveston National Laboratory, Yale University, University of Maryland Human Virology Institute, HIV/AIDS Vaccine Immunology Center, National Cancer Institute, National Institutes of Health AIDS Division, Bill And the Melinda Gates Foundation, the International AIDS Vaccine Initiative, the AIDS Vaccine Trial Network and the AIDS Clinical Trial Group. Profectus is funded by Cross Atlantic Capital Partners (“XACP”) in Radnor, Pennsylvania. The main investor in XACP is the Pennsylvania Public School Employees Retirement System (“PSERS”). For more information, please visit www.profectusbiosciences.com

Endorphina programming a software slots

The EiG show in Berlin was a massive success this year. After a full year, it was a pleasure to be back in Berlin for the second time to share a special program and our newest game at the energizing event.

After the skyrocketing space adventures with our 2027 ISS game, we decided to take visitors into a world where majestic kings and queens ruled the kingdoms – but this time, as royal cats. Our Aristocats game is presented in a polished design to make you feel like you’re a guest in a noble and aristocratic, purrfect, and furry kingdom filled with only the best symbolic kittens and cats to jump on the reels.

To support the launch of our game, we’ve decided to team up with a local animal shelter in hopes to encourage others to donate what they can to these volunteers. All contributions that are made will go directly to the shelter, to aid the lives of the abandoned cats to prepare them for a proper and loving adoption.

Everyone who visited our stand at the show could interact and meet 5 super cute and cuddly kittens from the shelter. This attracted a lot of attention and many people found themselves stuck at our stand, connecting with the kittens and taking photos with these purrfect little friends.

We are very happy that our new game was very well received by the audience at the show and that the purry and furry small little kittens were able to make everyone’s day – as how everyone’s contributions to the shelter were able to help brighten their lives.

Endorphina Games is a online casino developers since 2012.

Endorphina Ltd is registered under the laws of the European Union member state of Malta. It has registration number C77672 with office address at 27/28, Triq Torri Wejter, Birkirkara BKR 4730. Endorphina Limited operations are regulated by the Malta Gaming Authority (MGA) under the license MGA/CL4/xxx/xxxx (currently under application). Find out more about the MGA at www.mga.org.mt. Gambling can be addictive, play responsibly.

Contacts:

mail : mail@endorphina.com
www : Endorphina.com
tel: +420 222 564 222

More details can be found at our internet gambling software providers online website location.

The Cube: Condo Hotel

Imagination has finally become reality. As a magnificent five star condo hotel, The Cube is currently being developed within Dubai Sports City. Towering 27 floors in this prime location, The Cube will be nestled in a spectacular urban landscape with breathtaking views of Sports City and accented by a glorious man-made lake. The Cube is merely 20 minutes from the Dubai International Airport, and 10 minutes from Media and Internet City, also the wonderful Jumeirah Coastline, Burj Al Arab, Dubai Marina, and the best golf courses. In short, the Cube is a prestigious condo hotel, delivering the finest quality features and world class amenities, all in the heart of Dubai Sports City. Continue Reading “The Cube: Condo Hotel”

Marketing for dentist business London

One of the keys to a successful web design project is ensuring that you are regularly and clearly communicating your needs to your graphic designers and project manager. You will get the most out of your investment if you accurately communicate what you want to see on your design, provide examples of other work you appreciate, and ask questions on subjects that you are unsure about. Many of those involved in the web design aspect of a project enjoy hearing a clients ideas from the start and welcome any goal-based requests prior to embarking on their Website Design Ideas work. Extra info on Websites for dentists London.

Must have features ? Limit the number of images and photos you use. A digital photo album of beaming people with sparkling pearl-white teeth can help people relate to your site, but ultimately its the quality of your content and breadth of services that will help you acquire and retain patients. Moreover, too many images will affect how quickly your website fully loads in a browser (not everyone has top-tier high-speed internet access) and will use more data for mobile viewers.

Include a clear menu. Include a dropdown menu to group your content and make it easily accessible across your site. Doing so keeps navigating your site a breeze, and it too helps prevents visitors from getting lost.

Before you spend one penny building a website or revamping an existing one, decide what you want people to think of you when they get to your site. After deciding what impression you want people to have about you, create a visual representation of it, selecting fonts, features, and colors that will make your site match your vision.

If you need inspiration, look at other websites that project the same look and feel you want to project, or reach out to colleagues or designers for help. Your website needs to present a look, feel, and approach thats consistent with all of your online and offline patient interactions.

Client testimonials can set you apart in an instant, and its easily the fastest way to earn the trust of new patients. My dentist automatically sends out emails after every cleaning asking for reviews. If submitted, they ask if they can share these reviews publicly, and if so, theyll list them on the site.

Even if you only get one great review for every ten emails you send out, youll have a page full of great testimonials in no time that you can use to build trust.

design4dentists are passionate about dental SEO marketing. We aim to work closely in partnership with you to ensure your website and online marketing can generate the patients you wish for. We have the knowledge and expertise to guide you in developing your website to enable it to achieve results.

Design4dentists
https://www.design4dentists.com/
7e Dukes Yard
Acme Road
Watford
WD24 5AL
United Kingdom

Existing-Home Sales Soar 5.6 Percent in November to Strongest Pace in Over a Decade

Existing-home sales surged for the third straight month in November and reached their strongest pace in almost 11 years, according to the National Association of Realtors?. All major regions except for the West saw a significant hike in sales activity last month.

Lawrence Yun is chief economist and senior vice president of research at the National Association of Realtors(r). Yun oversees and is responsible for a wide range of research activity for the association including NAR’s Existing Home Sales statistics, Affordability Index, and Home Buyers and Sellers Profile Report. He regularly provides commentary on real estate market trends for its 1 million Realtor(r) members. (PRNewsFoto/National Association of Realtors)

Total existing-home sales1, https://www.nar.realtor/existing-home-sales, which are completed transactions that include single-family homes, townhomes, condominiums and co-ops, jumped 5.6 percent2 to a seasonally adjusted annual rate of 5.81 million in November from an upwardly revised 5.50 million in October. After last month’s increase, sales are 3.8 percent higher than a year ago and are at their strongest pace since December 2006 (6.42 million).

Lawrence Yun, NAR chief economist, says home sales in most of the country expanded at a tremendous clip in November. “Faster economic growth in recent quarters, the booming stock market and continuous job gains are fueling substantial demand for buying a home as 2017 comes to an end,” he said. “As evidenced by a subdued level of first-time buyers and increased share of cash buyers, move-up buyers with considerable down payments and those with cash made up a bulk of the sales activity last month. The odds of closing on a home are much better at the upper end of the market, where inventory conditions continue to be markedly better.”

The median existing-home price3 for all housing types in November was $248,000, up 5.8 percent from November 2016 ($234,400). November’s price increase marks the 69th straight month of year-over-year gains.

Total housing inventory4 at the end of November dropped 7.2 percent to 1.67 million existing homes available for sale, and is now 9.7 percent lower than a year ago (1.85 million) and has fallen year-over-year for 30 consecutive months. Unsold inventory is at a 3.4-month supply at the current sales pace, which is down from 4.0 months a year ago.

“The anticipated rise in mortgage rates next year could further cut into affordability if these staggeringly low supply levels persist,” said Yun. “Price appreciation is too fast in a lot of markets right now. The increase in homebuilder optimism must translate to significantly more new construction in 2018 to help ease these acute inventory shortages.”

First-time buyers were 29 percent of sales in November, which is down from 32 percent both in October and a year ago. NAR’s 2017 Profile of Home Buyers and Sellers – released earlier this year5 – revealed that the annual share of first-time buyers was 34 percent.

Matching the highest share since May, all-cash sales were 22 percent of transactions in November, which is up from 20 percent in October and 21 percent a year ago. Individual investors, who account for many cash sales, purchased 14 percent of homes in November, up from 13 percent last month and unchanged from a year ago.

“The elevated presence of investors paying in cash continues to add a layer of frustration to the supply and affordability headwinds aspiring first-time buyers are experiencing,” said Yun. “The healthy labor market and higher wage gains are expected to further strengthen buyer demand from young adults next year. Their prospects for becoming homeowners will only improve if more lower-priced and smaller-sized homes come onto the market.”

Properties typically stayed on the market for 40 days in November, which is up from 34 days in October but down from 43 days a year ago. Forty-four percent of homes sold in November were on the market for less than a month.

Realtor.com?’s Market Hotness Index, measuring time on the market data and listings views per property, revealed that the hottest metro areas in November were San Jose-Sunnyvale-Santa Clara, Calif.; Vallejo-Fairfield, Calif.; San Francisco-Oakland-Hayward, Calif.; San Diego-Carlsbad, Calif.; and Stockton-Lodi, Calif.

According to Freddie Mac, the average commitment rate for a 30-year, conventional, fixed-rate mortgage increased for the second straight month to 3.92 percent in November from 3.90 percent in October. The average commitment rate for all of 2016 was 3.65 percent.

On the topic of tax reform, NAR President Elizabeth Mendenhall, a sixth-generation Realtor? from Columbia, Missouri and CEO of RE/MAX Boone Realty, says it’s good news homeowners can continue to count on tax incentives such as the mortgage interest deduction and the state and local tax deduction.

“Only 6 percent of homeowners have mortgages exceeding $750,000, and only 5 percent pay more than $10,000 in property taxes, but most homeowners won’t itemize under the new regime,” she said. “While we’re pleased that important homeownership incentives such as the capital gains exclusion survived in conference, additional changes are required to truly incentivize homeownership in the tax code.”

Distressed sales6 – foreclosures and short sales – were 4 percent of sales for the fourth straight month in November, and are down from 6 percent a year ago. Three percent of November sales were foreclosures and 1 percent were short sales.

Single-family and Condo/Co-op Sales
Single-family home sales grew 4.5 percent to a seasonally adjusted annual rate of 5.09 million in November from 4.87 million in October, and are now 3.2 percent above the 4.93 million pace a year ago. The median existing single-family home price was $248,800 in November, up 5.4 percent from November 2016.

Existing condominium and co-op sales increased 14.3 percent to a seasonally adjusted annual rate of 720,000 units in November, and are now 7.5 percent above a year ago. The median existing condo price was $242,500 in November, which is 8.8 percent above a year ago.

Regional Breakdown
November existing-home sales in the Northeast leaped 6.7 percent to an annual rate of 800,000, (unchanged from a year ago). The median price in the Northeast was $273,600, which is 4.0 percent above November 2016.

In the Midwest, existing-home sales jumped 8.4 percent to an annual rate of 1.42 million in November, and are now 6.8 percent above a year ago. The median price in the Midwest was $196,100, up 8.8 percent from a year ago.

Existing-home sales in the South expanded 8.3 percent to an annual rate of 2.34 million in November, and are now 4.0 percent higher than a year ago. The median price in the South was $216,200, up 4.8 percent from a year ago.

Existing-home sales in the West declined 2.3 percent to an annual rate of 1.25 million in November, but are still 2.5 percent above a year ago. The median price in the West was $375,100, up 8.2 percent from November 2016.

The National Association of Realtors?, “The Voice for Real Estate,” is America’s largest trade association, representing 1.3 million members involved in all aspects of the residential and commercial real estate industries.

NOTE: For local information, please contact the local association of Realtors? for data from local multiple listing services. Local MLS data is the most accurate source of sales and price information in specific areas, although there may be differences in reporting methodology.

1 Existing-home sales, which include single-family, townhomes, condominiums and co-ops, are based on transaction closings from Multiple Listing Services. Changes in sales trends outside of MLSs are not captured in the monthly series. NAR rebenchmarks home sales periodically using other sources to assess overall home sales trends, including sales not reported by MLSs.

Existing-home sales, based on closings, differ from the U.S. Census Bureau’s series on new single-family home sales, which are based on contracts or the acceptance of a deposit. Because of these differences, it is not uncommon for each series to move in different directions in the same month. In addition, existing-home sales, which account for more than 90 percent of total home sales, are based on a much larger data sample – about 40 percent of multiple listing service data each month – and typically are not subject to large prior-month revisions.

The annual rate for a particular month represents what the total number of actual sales for a year would be if the relative pace for that month were maintained for 12 consecutive months. Seasonally adjusted annual rates are used in reporting monthly data to factor out seasonal variations in resale activity. For example, home sales volume is normally higher in the summer than in the winter, primarily because of differences in the weather and family buying patterns. However, seasonal factors cannot compensate for abnormal weather patterns.

Single-family data collection began monthly in 1968, while condo data collection began quarterly in 1981; the series were combined in 1999 when monthly collection of condo data began. Prior to this period, single-family homes accounted for more than nine out of 10 purchases. Historic comparisons for total home sales prior to 1999 are based on monthly single-family sales, combined with the corresponding quarterly sales rate for condos.

2 November’s monthly increase of 5.6 percent is the largest monthly gain since December 2015 (12.1 percent), which was influenced by delayed closings resulting from the rollout of the Know Before You Owe initiative in late 2015.

3 The median price is where half sold for more and half sold for less; medians are more typical of market conditions than average prices, which are skewed higher by a relatively small share of upper-end transactions. The only valid comparisons for median prices are with the same period a year earlier due to seasonality in buying patterns. Month-to-month comparisons do not compensate for seasonal changes, especially for the timing of family buying patterns. Changes in the composition of sales can distort median price data. Year-ago median and mean prices sometimes are revised in an automated process if additional data is received.

The national median condo/co-op price often is higher than the median single-family home price because condos are concentrated in higher-cost housing markets. However, in a given area, single-family homes typically sell for more than condos as seen in NAR’s quarterly metro area price reports.

4 Total inventory and month’s supply data are available back through 1999, while single-family inventory and month’s supply are available back to 1982 (prior to 1999, single-family sales accounted for more than 90 percent of transactions and condos were measured only on a quarterly basis).

5 Survey results represent owner-occupants and differ from separately reported monthly findings from NAR’s Realtors?Confidence Index, which include all types of buyers. Investors are under-represented in the annual study because survey questionnaires are mailed to the addresses of the property purchased and generally are not returned by absentee owners. Results include both new and existing homes.

6 Distressed sales (foreclosures and short sales), days on market, first-time buyers, all-cash transactions and investors are from a monthly survey for the NAR’s Realtors? Confidence Index, posted at nar.realtor.

NOTE: NAR’s Pending Home Sales Index for November is scheduled for release on December 27, and Existing-Home Sales for December will be released January 24; release times are 10:00 a.m. ET.

From https://www.prnewswire.com/news-releases/existing-home-sales-soar-56-percent-in-november-to-strongest-pace-in-over-a-decade-300573924.html

Slots gaming : Mega Moolah, a very good slots game

Microgaming’s most famous and highest-paying progressive has been going for ten years now and the size of the progressive jackpots being won, just keeps on increasing.

First off, let us explain a little about the Mega Moolah jackpot game and how it is actually available in more than one theme. While most people are well aware that Mega Moolah is the big progressive jackpot game, you can actually play several other slots that share the same huge jackpot fund. In this article, we are going to primarily focus on the original Wild Africa themed slot for the review, but you can attempt to win the progressive playing any of the three other themes; American, Egyptian, and Holiday theme.

Now that we understand that you can land the Mega Moolah jackpot playing more than one slot, it’s now time to explain that the Mega Moolah progressive jackpot bonus game contains not just one jackpot, but four. The jackpot bonus game is triggered randomly, however the player may increase the chances of triggering the bonus game by betting the maximum amount.

Please note that the default currency of Mega Moolah is Pound Sterling (GBP). However the game can be played world wide and in various different currencies. This means that when a jackpot is won in a currency other than GBP, say, Canadian Dollars, then the amount is paid out in CAD, not GBP. Also note that only when the jackpot is actually won in GBP does the jackpot reset to 1 million. When won in another currency the jackpot resets to a converted value. For example, if the jackpot value is GBP 10 million but it is won by a player playing in Canadian dollars, then the player has won CAD 10 million, which is around GBP 6.3 million. Therefore the jackpot would reset to around GBP 3.7 million (depending on the forex of the day).

The progressive jackpot game takes on a different form to the base game slot behind it as it is a wheel. On that reel are four different coloured sectors, each sector, depending on the colour, corresponds to one of the four Mega Moolah jackpots available. Mini, Minor, Major and Mega.

Obviously, there are more slots on the reel for the smaller jackpots and when this wheel is triggered, the wheel is spun and when the wheel comes to rest, the jackpot the selector is pointing to is the one won by the player. Most of the time players will hit the Mini or Minor Jackpots, but occasionally a Major Jackpot is won but every so often, the Mega Jackpot is triggered and somebody somewhere celebrates a guaranteed 1 million+ credit win and often far, far more than that, as can be seen on our Mega Jackpot tracker page.

You can only randomly trigger this Jackpot wheel however if you are playing the Mega Moolah base game, so now is a good time to learn a little more about this most popular of progressive slots.

The theme of the original Mega Moolah slot is an African Safari and it is a 5×3 reel slot, with 25 pay lines in operation and a maximum bet size of 125 coins. That equates to around 6.25 per spin, so you don’t have to break the bank betting large sums on every spin in order to give yourself a chance of the jackpot.

In addition to this game, there are Egyptian, Summer and Car themed variants of the slot. Mega Moolah Isis, Mega Moolah Summertime and Mega Moolah 5 Reel Drive all share the same 4 progressive jackpots with the original game. As well as the different themes, there are also differences across the other games in terms of the number of free spins that can be won, the multipliers, as well as a gamble feature in some, which does not appear in the original game. This game may have been around for a while, but it has not lost any of its appeal. The graphics are bright and colourful, and the sound effects match the wild African theme perfectly. The hope of hitting the progressive jackpot adds a lot of excitement to the game, but as with all progressives, chances of playing the bonus game are minimal. Yet luckily there are plenty of regular, smaller payouts, that enable you to keep playing and potentially boost your bank balance. Whats more, the free spins and wilds also offer the chance to multiply winnings. If you have played Mega Moolah, why not share your experiences with other players. You can use the comment form below to add your thoughts.

More @ Mega Moolah Progressive jackpot.

Have you ever asked yourself why you play slots at all? Is it maybe because you find their spinning reels relaxing, or perhaps because you enjoy their colourful visuals? For a lot of you, the answer is a lot more simple its because of the money! While poker and blackjack offer seasoned gamblers the chance to become millionaires, slots have always been there to provide the same opportunity to people who cant bluff or count cards all that well. And while most winnings on slot machines arent particularly high unless you get a bonus game or something like that, theyre not why were here no, we came for the reels, but we definitely stayed for the jackpot! The promise of a life-changing, multi-million pound jackpot has enticed people for years, and in the online space, theres really no jackpot that is more famous than the one Mega Moolah offers. Never dropping below 1,000,000, this progressive jackpot has made several people millionaires already, and for a while it also held the record for biggest jackpot won from an online slot, so draw your own conclusions!

Cryolife news

Asian’s Godfather of Cord Blood, Professor Takahashi Tsuneo Joined the “Cryolife Cord Blood Bank” and “Hong Kong Medisun”

In May 2017, CRYOLIFE Cord Blood Bank (Hong Kong Medisun Medical Group members) formally appointed the Godfather of Cord Blood in Asia, Japanese regenerative medicine expert Professor Takahashi Tsuneo as the Chief Scientist. Professor Takahashi will lead all the cord blood stem cell research projects. Professor Takahashi has eras of experience in the field of regenerative medicine. In the past few decades, Professor Takahashi has established the standards of the Cryo-Cord Blood in Asia and lead a new prospective in the application and development of the cord blood industry.

It is well believes that by the joining of Professor Takahashi will convey a new development stage in the field of cord blood stem cells in Hong Kong. It will bring new opportunities for the expansion of Medisun Medical Group and the Cryolife Cord Blood Bank.

Professor Takahashi Tsuneo is committed to the field of regenerative medicine for more than 40 years (mainly in the field of stem cells and cord blood bank). Currently he serves as Chief Executive Officer of Japan LIFEBANK and Chief Scientist of Hong Kong Cryolife Cord Blood Bank (Cryolife is a members of the Medisun Group). Prof. Takashi Tsuneo graduated from the Hokkaido University in Sapporo, Japan with a Ph.D. degree. He became the scientist in the Red Cross of Bethesda, Maryland. He later worked at the Research center for Arthritis, Diabetes and Kidney diseases of the National Institutes of Health in Bethesda, Maryland. Professor Takahashi Tsuneo returned to Japan, became the Red Cross Hokkaido Blood Center’s Research Director in Sapporo. Professor Takahashi is not only a founding member of the International Cord Blood Bank Alliance (NETCORD), but also Director of the Tokyo Cord Blood Bank Cell Treatment Center at the University of Tokyo, Japan, and Director of Cellular Research and Development for research center for cell therapy in New York. Professor Takahashi is a Visiting Professor at a number of well-known institutions, including: Department of Cellular Processing, Institute of Medical Sciences, University of Tokyo, Head of Hematology, Tokyo University Hospital, Head of Embryonic Stem Cell Research, Faculty of Forensic Medicine, Kyoto University, Kobe University Institute of Medicine and Pathology, and Department of Medicine, Peking University, China.

Application of Cord Blood

Cord blood is originated in the fetus, and collected at the umbilical cord ligation when separated from the residual placenta. Nearly a decade of research and discovered that umbilical cord blood contain the human hematopoietic and the hematopoietic stem cells of the immune system. It can be used for hematopoietic stem cell transplantation, for the treatment of more than 80 kinds of diseases. Thus, the cord blood has become an important source of hematopoietic stem cells, especially for no directly related family members. The hematopoietic stem cells is a very important human biological for treatment of diseases.

Worldwide, cord blood has been used to treat various types of Leukemia, Aplastic Anemia, Lymphoma, Multiple Myeloma, Neuroblastoma, Mucopolysaccharide disease, Thalassemia, Bone Marrow Dysplasia syndrome, Primary Immunodeficiency Disease, Chronic Granuloma and other 80 kinds of diseases.

Clinical application case

* The world’s first cord blood transplantation: In 1988, a 5-year-old French boy, suffering from Cooley’s Anemia has been treated with the cord blood transplantation and with completely recovered.
* The world’s first autologous cord blood transplantation: In 1997, a 14-month-old Brazilian girl, with autologous cord blood successfully cured Neuroblastoma.
* The world’s first double dosages of cord blood transplantation: In 2000, the Institute of Hematology of the Peking University used the world’s first double dose of cord blood transplantation for the treatment of Acute Lymphoblastic Leukemia with good result. Now, the patient weight of 95 kg, is having a healthy life.
* Asia’s first autologous cord blood transplantation: In 2009, Beijing Children’s Hospital, a pediatric patient using his own cord blood for the treatment of Neuroblastoma. This is the first case of autologous cord blood treatment for pediatric case. The baby is treated and being fine after the transplantation.
* China treated a youngest and light weight baby: In 2009, Shanghai Dao Pei Hospital has successfully treated a 2 months old baby only weight – 5 kg, by using the cord blood transplantation treatment for Primary Immunodeficiency Disease.
* In China, the first mother received the son’s cord blood transplantation as treatment: In 2009, Chongqing Xinqiao Hospital, a female patient suffering from an Acute Non-Lymphocytic Leukemia was treated by using her son’s umbilical cord blood, together with his husband’s bone marrow for transplantation. She was discharged from the Intensive Care Unit after one month from the transplantation. This is the first case of mother using her child’s cord blood for transplantation.

Treatment prospects

Cell therapy has been a biological way for the treatment of a number of diseases in the 21st century. At the end of May 2014, the worldwide of related clinical research on the cord blood cell therapy, registered with the United States National Institutes of Health (NIH) reached a total of 928.

CRYOLIFE Cord Blood Bank – Hong Kong’s first private cord blood bank

CRYOLIFE Cord Blood Bank is the only one in Hong Kong with the most international professional certification, and is highly recommended by gynecologist, physicians and parents. CRYOLIFE was established in 1996 to create the first private cord blood storage program in Asia. Prior to the establishment of the cord blood bank in Japan, Singapore, mainland China, Taiwan and Malaysia. Cryolife upgrades the standards in the development and research in the laboratory equipment. It is the leader in Hong Kong and Asian in the cord blood industry. CRYOLIFE has been recognized by the American Association of Blood Banks (AABB) since 2007 as one of the world’s first recognized AABB-approved cord blood banks, and range the first 50 in the Cord Blood Bank’s list. Continuous assessment were done in 2009, 2011, 2013 and 2015 and has successfully passed the review, and gain the AABB certification until the end of 2017. The company is the only one in Hong Kong which has obtained a 10 consecutive years’ certification in the private cord blood bank. (In February 2017) Hong Kong Medisun Medical Group acquired 51% stake in CRYOLIFE Cord Blood Bank as its controlling shareholder.)

MEDISUN MEDICAL GROUP

Headquartered in Hong Kong, Headquartered in Hong Kong, the company is committed to investing in R & D and commercialization of global regenerative medicine products, as well as professional medical investment groups in top hospitals and treatment centers.

Medisun invests extensively in regenerative medicine and stem cell patented technology, including stem cell therapy for heart failure, stem cell therapy for liver disease, kidney disease, neurological diseases, cancer, AIDS, and immune cell therapy for a variety of cancers. Medisun Medical and the US Mayo Clinic, Harvard University Stem Cell Research Institute, Johns Hopkins School of Life Science Center launched a long-term cooperation program, co-investment in regenerative medicine and stem cell therapy technology. Medisun collaborates with them as the business owned holdings and holds global intellectual property rights.

The Medisun Regenerative Medical Center is located in Kowloon, Hong Kong , with 50,000 square feet of stem cell GMP production base, cancer treatment center and anti-aging center, bringing together European, Japanese, American and individual Chinese experts for rigorous professional development process by providing immune cell therapy and a variety of stem cell treatments. Medisun is also the Asian Center, a representative of the Mayo Clinic Asia service agencies. It provides Mayo remote consultation, the second diagnosis and treatment, so that Chinese patients can not enjoy the authority of the medical services. Mayo Clinic provides more than three thousand biomedical tests for the most predictable health protection for our customers’ health.

Medisun Regenerative Medicine Center (Mayo Asia Medical Service Center | Cancer Treatment Center | Anti-Aging Center)

Medisun Medical Laboratory (Hong Kong)

Source : http://www.medisun.hk/

Mig Welder Ireland

Looking for plasma cutter for a project in Ireland? You can check this complete welding solutions online store at Migwelders.ie.

Oxford Welder provider Ireland : MIG Welders are extremely popular because they tend to cost less than TIG or Stick welders with comparable power and features, are extremely easy to learn, and can tackle a wide variety of projects. Since the filler metal is fed through the MIG welding torch, welders can use both hands to hold the torch steady rather than using one hand to add filler metal, as in TIG welding. The wire feeder also makes MIG welding up to four times faster.

The MIG welding process uses an inert gas to shield the weld and to keep it free from impurities. This makes MIG welding very neat and easy to clean up since there isn’t anything to chip away, which is typical for Stick welding.

Some tips on choosing the best welding equipment and also some industry news:

Weight of machine Do you require a machine that needs to be moved around and transported to jobs, or will it remain within a workshop?

Take into account the duty cycle of the machine!! You may need 160amps and a machine may state that it does this, but it could only be at 15% duty cycle, which means it could only weld at 160amps for 1.5mins out of every 10mins? Unless you are only do very short welds its best to work on a 35% duty cycle when choosing your machine.

Where the machine is manufactured and are replacement parts available in your country? Time and time again we have customers who cannot get spares for their machine when it breaks down. MigWelder.Ie has all the spare parts for all the machines on the shop.

Purchasing a welder is an important long term decision that can add extra income to your bottom line, save on repair costs, and make it possible to complete a wide array of hobbies. The options can be overwhelming, and that is why we’ve put together this welder buying guide. You’ll find important details to consider, a comparison of welder types, and information about the top selling brands from Baker’s Gas and Welding.

One of the most important questions to consider when selecting a welder isn’t what projects it will be used for in the next week, month, or even year. Those interested in buying a welder need to ask if they see themselves using it more frequently in the future for many different kinds of projects.

TWS Direct Ltd. Unit 1 M54 Space Centre.
Halesfield 8. Telford. Shropshire. TF7 4QN
Phone :
+44 (0) 1952 582 260
Website: https://www.migwelders.ie/
Email :sales@weldingsuppliesdirect.co.uk; MIGWELDERS.IE are a welding equipment and welding consumables supplier based in Shropshire, UK. We strive to provide the best MIG welders, TIG welders and welding consumables in Ireland. We are the home of Oxford welders in Ireland, with plenty of machines carried in stock for fast delivery!